During the past decade, Minnesota Heart Failure Network conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Heart Failure Network" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Heart Failure Clinical Research Network" with 1 trials as a collaborator, "Nuwellis, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Heart Failure Network" are "Heart Failure" (4 trials), "Acute Heart Failure" (1 trials) and "Mitral Valve Insufficiency" (1 trials). Many other conditions were trialed in "Minnesota Heart Failure Network" in a lesser frequency.

Most popular intervention types in "Minnesota Heart Failure Network" are "Drug" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dopamine" (1 trials), "Furosemide-Continuous Infusion" (1 trials), "Furosemide-High Intensification" (1 trials) and "Furosemide-Low Intensification" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Heart Failure Network" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Minnesota Heart Failure Network". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Minnesota Heart Failure Network, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Heart Failure Network, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".